Shares of Cronos Group Inc. (NASDAQ: CRON) soared 5.41% in pre-market trading on Thursday, following the release of the company's impressive first-quarter financial results. The cannabis company reported earnings that significantly exceeded expectations and demonstrated robust year-over-year growth.

Cronos Group announced quarterly earnings of $0.02 per share, marking a remarkable 300% improvement from the $0.01 loss per share reported in the same period last year. This positive earnings surprise indicates a strong turnaround in the company's profitability.

In addition to the earnings beat, Cronos Group reported quarterly sales of $32.26 million, surpassing the analyst consensus estimate of $31.70 million by 1.79%. The revenue figure represents a substantial 27.58% increase compared to the $25.29 million recorded in the same quarter of the previous year. This growth in sales suggests that Cronos Group is successfully expanding its market presence and product offerings in the competitive cannabis industry.

Investors are reacting positively to these results, as evidenced by the pre-market stock surge. The strong financial performance may boost confidence in Cronos Group's business strategy and growth prospects, potentially attracting more interest from both institutional and retail investors in the cannabis sector.